History

1981	Feb	Japan Lifeline Co., Ltd. established in Toshima-ku, Tokyo, Japan Released cardiac pacemaker Opened Sapporo, Osaka and Fukuoka sales offices

1987	Sep	Opened Sendai and Hamamatsu sales offices

1989	Mar	Released PTCA balloon catheter
	Jul	Opened Aomori and Nagoya sales offices
	Sep	Opened Hiroshima sales office

1990	Mar	Released prosthetic heart valve
	Sep	Opened Kagoshima sales office

1991	Jul	Opened Hokuriku sales office Released vascular graft

1992	Jan	Opened logistics center (currently Haneda Logistics Center)
	Feb	Opened Urawa sales office
	Apr	Opened Tokyo (currently Tokyo sales officeⅠ) and Matsuyama sales offices
	Sep	Opened Yokohama and Okayama sales offices

1993	Oct	Opened Niigata sales office

1994	Jan	Released PTCA guide wire
	Mar	Released PTCA guiding catheter
	Jun	Opened Kitakyushu sales office
	Oct	Opened Akita and Takamatsu sales offices Released pump-oxygenator

1995	Nov	Released oxygenator and electrophysiology catheter

1996	Nov	Opened Koriyama sales office

1997	Oct	Opened Kyoto sales office
	Dec	Registered over-the-counter stock with the Japan Securities Dealers Association, initial public offering

1998	Feb	Released PTCA stent

1999	Aug	Established Research center (currently 1st R&D Division and 2nd R&D Division)

2000	Oct	Established Ukima factory (manufacturing facility)

2001	Apr	Opened Matsumoto sales office Released PTCA guide wires as an in-house product
	Aug	Released ICD (implantable cardioverter defibrillator)
	Oct	Opened Nagasaki sales office

2003	Apr	Opened Chiba sales office Released ablation catheter as an in-house product

2004	Apr	Released electrophysiology catheter as an in-house product Opened Yonago sales office

2005	Aug	Released atrial septal defect closing device
	Nov	Opened Okinawa regional office (currently sales office)

2006	Apr	Acquired ISO13485:2003 certification (For the Quality Assurance Division, Ichihara Factory, Toda Factory,Oyama Factory, Haneda Logistics Center,and Kansai Logistics Center) Opened Kumamoto regional office (currently sales office)
	Dec	Released CRT-D (cardiac resynchronization therapy defibrillators)

2007	Jun	Entered into exclusive sales agreement for Sorin Group CRM （MicroPort CRM）(cardiac rhythm management) products
	Jul	Opened Tennoz Accademia (Education center)
	Sep	Merged with Sorin Group Japan Co., Ltd. through absorption-type merger Opened Morioka regional office

2008	Jan	Relocated head office to shinagawa-ku, Tokyo

2009	Feb	Subsidized JUNKEN MEDICAL Co., Ltd.（formerly Ube Junken Co.,Ltd.）
	Apr	Released vascular grafts manufactured by JUNKEN MEDICAL Co., Ltd.

2010	May	Opened Ibaraki regional office (currently sales office)
	Oct	Opened Kobe sales office
	Dec	Estbablished Ichihara factory by JUNKEN MEDICAL Co., Ltd.

2011	Oct	Opened Tama sales office

2012	Jan	Established Toda factory
	Apr	Opened Gunma and Oita regional offices (currently sales offices)
	Oct	Released internal atrial cardioversion catheter as an in-house product
	Nov	Released biological heart valve
	Dec	Established HEART BRAINS INC.

2013	May	Released thoracic stent graft Released radio-frequency transseptal needle

2014	Apr	Released PTCA balloon catheter as an in-house product
	Jul	Released frozen elephant trunk manufactured by JUNKEN MEDICAL
	Oct	Established Oyama Factory

2015	Apr	Released esophageal temperature monitoring catheter as an in-house product
	Dec	Opened Numazu regional office

2016	Jan	Released abdominal stent graft Merged with HEART BRAINS INC. through absorption-type merger
	May	Changed exchange market from the JASDAQ (Standard) market to the First Section of the Tokyo Stock Exchange
	Jul	Opened Hakodate and Mie (currently sales office) regional offices

2017	Apr	Merged with JUNKEN MEDICAL Co., Ltd. through absorption-type merger Opened Tokyo sales office Ⅱ and Fukui (currently sales office), Nara (currently sales office), Himeji (currently sales office), Yamaguchi and Miyazaki regional offices
	May	Opened Asahikawa and Kushiro regional offices
	Jun	Released colonic stent as an in-house product
	Jul	Established JLL Malaysia Sdn. Bhd. (currently consolidated)
	Oct	Opened Utsunomiya and Shizuoka regional offices (currently sales offices)

2018	Mar	Released drug-eluting stent
	Apr	Opened Kochi regional office
	Jul	Opened Kansai Logistics Center Released endoscopic laser ablation catheter
	Nov	Entered into exclusive sales agreement for Boston Scientific corporation for CRM (cardiac rhythm management) products

2019	Apr	Released S-ICD (subcutaneous implantable cardioverter defibrillator)
	Nov	Established JLL Korea Co.,Ltd. (non-consolidated)
	Dec	Released radiofrequency ablation system for the treatment of liver cancer as an in-house product

2020	Jun	Opened Yamagata and Yamanashi regional offices Estbablished Malaysia factory by JLL Malaysia Sdn. Bhd.

2021	Dec	Released intravascular embolic coil

2022	Feb	Released implantable treatment device for obstructive sleep apnea (OSA)
	Apr	Changed exchange market from the First Section to Prime of the Tokyo Stock Exchange
	Aug	Entered into exclusive sales agreement for Wallaby Medical (HK) Limited for Neurovascular Products
	Oct	Released Patch-Type ECG Recorder

2023	May	Released thrombus aspiration catheter Acquired MDSAP (Medical Device Single Audit Program)
	Oct	Released vascular closure device for femoral veins Entered into exclusive distribution agreement for Meril Life Sciences Pvt. Ltd. for transcatheter heart valve

2024	Sep	Released stent retriever

2025	Mar	Entered into an exclusive distribution agreement for Philips Japan, Ltd. for Lead management products